109 related articles for article (PubMed ID: 32078687)
1. A new role for an old cytokine: GM-CSF amplifies GVHD.
Waller EK
Blood; 2020 Feb; 135(8):520-521. PubMed ID: 32078687
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
Piper C; Zhou V; Komorowski R; Szabo A; Vincent B; Serody J; Alegre ML; Edelson BT; Taneja R; Drobyski WR
Blood; 2020 Feb; 135(8):568-581. PubMed ID: 31880771
[TBL] [Abstract][Full Text] [Related]
3. Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.
Piper C; Hainstock E; Yin-Yuan C; Chen Y; Khatun A; Kasmani MY; Evans J; Miller JA; Gorski J; Cui W; Drobyski WR
Blood Adv; 2022 May; 6(9):2791-2804. PubMed ID: 35015822
[TBL] [Abstract][Full Text] [Related]
4. Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.
Gartlan KH; Koyama M; Lineburg KE; Chang K; Ensbey KS; Kuns RD; Henden AS; Samson LD; Clouston AD; Lopez AF; MacDonald KPA; Hill GR
Blood Adv; 2019 Oct; 3(19):2859-2865. PubMed ID: 31585949
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
6. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
Koyama M; Hill GR
Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
[TBL] [Abstract][Full Text] [Related]
7. BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.
Ullrich E; Abendroth B; Rothamer J; Huber C; Büttner-Herold M; Buchele V; Vogler T; Longerich T; Zundler S; Völkl S; Beilhack A; Rose-John S; Wirtz S; Weber GF; Ghimire S; Kreutz M; Holler E; Mackensen A; Neurath MF; Hildner K
J Clin Invest; 2018 Mar; 128(3):916-930. PubMed ID: 29376889
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
[TBL] [Abstract][Full Text] [Related]
9. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.
Matera L; Galetto A; Geuna M; Vekemans K; Ricotti E; Contarini M; Moro F; Basso G
Immunology; 2000 May; 100(1):29-36. PubMed ID: 10809956
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells.
Tugues S; Amorim A; Spath S; Martin-Blondel G; Schreiner B; De Feo D; Lutz M; Guscetti F; Apostolova P; Haftmann C; Hasselblatt P; Núñez NG; Hottiger MO; van den Broek M; Manz MG; Zeiser R; Becher B
Sci Transl Med; 2018 Nov; 10(469):. PubMed ID: 30487251
[TBL] [Abstract][Full Text] [Related]
12. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.
Kim ML; Martin WJ; Minigo G; Keeble JL; Garnham AL; Pacini G; Smyth GK; Speed TP; Carapetis J; Wicks IP
Circulation; 2018 Dec; 138(23):2648-2661. PubMed ID: 30571257
[TBL] [Abstract][Full Text] [Related]
14. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.
Brown CB; Pihl CE; Kaushansky K
Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224
[TBL] [Abstract][Full Text] [Related]
15. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
16. G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation.
Joo YD; Lee WS; Won HJ; Lee SM; Kim HR; Park JK; Park SG; Choi IW; Choi I; Seo SK
Cytokine; 2012 Oct; 60(1):277-83. PubMed ID: 22819244
[TBL] [Abstract][Full Text] [Related]
17. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE
Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
19. Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy.
Yamada H; Chihara J; Hamada K; Matsukura M; Yudate T; Maeda K; Tubaki K; Tezuka T
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S73-6. PubMed ID: 9440549
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
